#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital growth hormone deficiency Renal cancer metastatic Chronic myelomonocytic leukaemia Crohn's disease Leiomyosarcoma Congenital megacolon HER2 gene amplification Lupus nephritis Mycobacterium abscessus infection Systemic mastocytosis Non-Hodgkin's lymphoma unspecified histology indolent Mucopolysaccharidosis III Neurodermatitis Ureteric cancer Malformation venous More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Basic Information Immunodeficiency congenital – Trials in Disease Activated PI3 kinase delta syndrome – Treatment Congenital hypotransferrinaemia – Treatment CADASIL – Basic Information Alagille syndrome Amyotrophic lateral sclerosis – Trials in Disease Glycogen storage disease type V – Treatment Usher’s syndrome Vascular malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anidulafungin Dazodalibep VGA039 Tas3351 LY3841136 SODIUM Sodium Phenylbutyrate CEFTAROLINE FOSAMIL Oms906 Betibeglogene Autotemcel Tisotumab Vedotin Clindamycin Phosphate Sulfur Hexafluoride Ima203Cd8 Ergocalciferol Bp Tipiracil Hydrochloride Betula Alba Pollen Extract Labetalol Hydrochloride Bemarituzumab Progesterone Tolu Balsam More therapies…

    Learn about Your Condition

    Nicotine dependence Essential thrombocythaemia Biliary adenoma Cognitive disorder Choroidal neovascularisation Follicular thyroid cancer Pruritus Glomerulonephritis acute Incontinence Abortion threatened Haemoglobinuria Retinopathy proliferative Meniere's disease Connective tissue disorder Rectal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Tolerability of TP-122 for Treating Ventilator-Associated Pneumonia in Adults

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Demerecviridae Bacteriophage Against Klebesiella Pneumoniae (113.073 Bp)
    • Drexlerviridae Bacteriophage Against Klebesiella Pneumoniae (45.423 Bp)
    • Myoviridae Bacteriophage Against Klebesiella Pneumoniae (169.802 Bp)
    France

  • Study on Metastatic Prostate Cancer: Evaluating [18F]FAPI-74 and Piflufolastat (18F) for Patients with Advanced Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    • Piflufolastat (18F)
    Finland

  • Study on the Effects of Dextromethadone Hydrochloride for Patients with Moderate to Very Severe Restless Legs Syndrome

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Restless legs syndrome
    Investigated Drugs:
    • Dextromethadone Hydrochloride
    Italy

  • Study on PET/CT Imaging with [18F]-AlF-FAPI-74 for Identifying Fibrosis and Inflammation in Patients with Progressive Pulmonary Fibrosis

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Pulmonary fibrosis
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    The Netherlands

  • Study on AP-01 for Patients with Acute Heart Failure (NYHA Class III or Higher)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Germany

  • Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Zongertinib
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Greece Hungary +7
Previous Page
1 … 870 871 872 873 874 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!